: Jian-an Wang
: Mesenchymal Stem Cells for the Heart From Bench to Bedside
: Springer-Verlag
: 9783540881506
: Advanced Topics in Science and Technology in China
: 1
: CHF 85.50
:
: Medizin
: English
: 113
: Wasserzeichen/DRM
: PC/MAC/eReader/Tablet
: PDF

Stem cell research has the potential to affect the lives of millions of people around the world. This research is now regularly front-page news, and realizing the promise of mesenchymal stem cells for yielding new medical therapies will require us to grapple with more than just scientific uncertainties. 'Mesenchymal Stem Cells for the Heart - From Bench to Bedside' presents the cytobiological characteristics of mesenchymal stem cells from the isolation, culture, transmembrane ion currents, migration and differentiation in vitro to the repairing of injured myocardium and tissue reconstruction in vivo, including the results of basic research and the real possibility for treatments and ultimately for cures for cardiac diseases for which adequate therapies do not exist. The book is intended for clinical stem cell researchers in cardiovasology, hematology, cytobiology, molecular biology, cell and tissue engineering, and other related fields.

Jian-an Wang, MD, PhD, Professor of Cardiology at Zhejiang University and investigator at Loma Linda University, Southern California, has broad expertise in the molecular and cellular biological processes underlying cardiovascular disease. He has won the Chinese Medical Science and Technology Medal of Honor.



Jian-an Wang, MD, PhD, Professor of Cardiology at Zhejiang University and investigator at Loma Linda University, U.S., has broad expertise in the molecular and cellular biological processes underlying cardiovascular disease. He has won the Chinese Medical Science and Technology Medal of Honor. He performs cardiac interventional treatment on more than 1000 cases per year, doing percutaneous coronary angiography (PTCA), percutaneous coronary angioplasty, radiofrequency catheterization ablation (RFCA), percutaneous closure of a residual ventricular septal defect (VSD), atrial septal defect (ASD) and patent ductus arteriosus (PDA) with the Amplatzer occluder, etc. He is also the chief editor of Electrocardiology Journal, Chinese editor of Circulation, European Heart Journal and American Heart Association Journals Best Selection, editor of Chinese Emergency Journal, Chinese Practical Medicine Journal, and Chinese Modern Clinical Medicine Journal.

Preface6
Contents7
MSCs Isolation and Culture Ex Vivo10
1.1 Cell Isolation11
1.1.1 Direct Adherence Method 1.1.1.1 Materials12
1.1.1.2 Procedures12
1.1.2 Density Gradient Centrifugation12
1.1.2.1 Materials13
1.1.2.2 Procedures14
1.1.3 Magnetic Microbead or Flow Cytometry Method15
1.2 Cell Culture16
1.2.1 Materials16
1.2.2 Procedures16
1.3 Cell Cryopreservation and Thawing17
1.3.1 Materials18
1.3.2 Procedures18
References18
2 MSCs Identification21
Xinyang Hu121
Abstract:21
2.1 Minimal Criteria22
2.2 Some Comments of the Criteria22
2.3 Other Methods23
2.3.1 Morphology characteristics23
2.3.2 Other Markers 2.3.2.1 SB- 1023
2.3.2.2 SH-2, SH-3, SH-423
2.3.2.3 Neural Ganglioside GD224
2.3.2.4 SSEA-424
2.4 Conclusion24
References25
3 Biological Characteristics of MSCs26
3.1 Surface Markers and Paracrine Characteristics26
3.1.1 Surface Markers26
3.1.2 Paracrine Characteristics of MSCs29
3.2 Electrophysiological Properties of MSCs and Their Electric Coupling with Cardiomyocytes30
3.2.1 Characterization of Ion Channels in MSCs30
3.2.1.1 Potassium Channels (K+ Channels)31
3.2.1.2 Calcium Channels (Ca2+ Channels)32
3.2.1.3 Sodium Channels (Na+ Channels)33
3.2.2 Why does an Individual Cell Express Different Currents?33
3.2.3 Electric Coupling of MSCs with Host Cardiomyocytes34
3.3 Proliferation of MSCs and Telomerase Properties38
3.3.1 Structure and Function of Telomeres and Telomerase39
3.3.2 Telomere and Telomerase in MSCs39
3.4 Multilineage Transdifferentiation of MSCs41
3.4.1 MSCs and Cardiomyogenesis42
3.4.2 Differentiation Fate of MSCs45
3.5 Immunological Characteristics of MSCs46
3.5.1 Immunological Characteristics of MSCs46
3.5.1.1 MSCs and T Lymphocytes47
3.5.1.2 MSCs and B Cells49
3.5.1.3 MSCs and APCs50
3.5.1.4 MSCs and NK Cells51
3.5.251
Studies51
3.5.3 Immune-related Properties of MSCs in Cardiology53
3.6 Conclusion53
References54
4 Utilization of MSCs for Repairing Cardiomyocytes66
4.1 Application of MSCs on Myocardial Infarction68
4.2 Application of MSCs on Cardiomyopathy and Chronic Heart Failure72
4.3 Conclusion74
References75
5 Current Status of MSCs in Clinical Application80
5.1 The Type and Number of Transplanted Cells86
5.2 Cell Preparation87
5.3 The Time Point and Pathway of Cell Transplantation87
5.4 Others88
5.5 Conclusion90
References90
6 MSCs as a Vector of Gene Engineering94
6.1 Adenoviruses and Angiogenesis-related Genes96
6.2 Adeno-associated Virus (AAV) and Anti- inflammation Related Genes97
6.3 Retrovirus and Anti-apoptosis Related Genes98
6.4 Lentivirus and Pacemaker Current Gene99
6.5 Conclusion100
References100
7 Feasibility of MSCs Transplantaion103
7.1 General Ethical Considerations104
7.2 Safety Issues104
7.3 Informed Consent106
7.4 Conclusion106
References107
8 Status and Expectation of MSCs Therapy108
8.1 Clinical Application and Outcomes109
8.2 Mechanism of Therapeutic Effects111
8.3 Expectations with MSCs Therapy112
References114
Index118